Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Using Index Level To Set Risk Tolerance helps you align your portfolio with your comfort and goals. Grasp practical steps to calibrate risk in real markets.
27,657 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
Soccer's biggest tournament is moving to North America in 2026 with an expanded field and a booming betting market. T...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Dubai is poised to test a new era of urban travel with Uber and Joby Aviation. This article breaks down what the 2026...
A recent SEC filing shows Brightlight Capital trimmed its Hilton stake by 79,500 shares, reducing the position's valu...
Thinking long-term about crypto? This guide highlights the best cryptocurrencies right long-term bets and shows you h...
As GLP-1 therapies reshape obesity treatment, investors eye the best weight loss drug stock bets for 2026. This guide...
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A high-profile casting announcement isn’t just entertainment news. It reveals how budgets, marketing, and risk affect...
July 2026 offers a compelling setup for patient investors. Here’s my top-ranked stock for July, why it stands out, an...
The AI spending spree has some investors on edge. This guide explains why three big tech leaders may weather the stor...